Back to Journals » Clinical and Experimental Gastroenterology » Volume 9

Profile of acotiamide in the treatment of functional dyspepsia

Authors Ueda M, Iwasaki E, Suzuki H

Received 3 August 2015

Accepted for publication 23 November 2015

Published 6 April 2016 Volume 2016:9 Pages 83—88


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Professor Andreas M Kaiser

Masahiro Ueda,1 Eisuke Iwasaki,1 Hidekazu Suzuki2

1Department of Internal Medicine, Division of Gastroenterology and Hepatology, 2Medical Education Center, Keio University School of Medicine, Tokyo, Japan

Abstract: Efficacy of acotiamide for improving symptoms in patients with functional dyspepsia was shown by several clinical trials. In a randomized, double-blind, placebo-controlled, parallel-group comparative Phase III trial conducted in Japan, 100 mg of acotiamide three times a day for 4 weeks was more effective than a placebo for improving symptoms, and quality of life. Acotiamide was well-tolerated treatment, with no significant adverse events. The aim of this review was to summarize the current evidence of the efficacy of acotiamide in the treatment of patients with functional dyspepsia.

Keywords: functional dyspepsia, acotiamide, acetylcholinesterase, Rome III

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]